G. Antonios

Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism

G. Antonios, 2016 .

Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X

Sascha Weggen, Gregory Antonios, T. Bayer, 2015, Scientific Reports.

N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody

A. Paetau, T. Bayer, L. Lannfelt, 2013, Acta neuropathologica communications.

N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody

A. Paetau, T. Bayer, L. Lannfelt, 2013, Acta Neuropathologica Communications.

SLC35B4, an Inhibitor of Gluconeogenesis, Responds to Glucose Stimulation and Downregulates Hsp60 among Other Proteins in HepG2 Liver Cell Lines

R. Mahfouz, F. Kobeissy, B. Wex, 2018, Molecules.

Super-Resolution Microscopy of Cerebrospinal Fluid Biomarkers as a Tool for Alzheimer's Disease Diagnostics.

T. Bayer, S. Rizzoli, A. Rábano, 2015, Journal of Alzheimer's disease : JAD.

Management of Metadata Types in Basic Cardiological Research

Ulrich Sax, Bartlomiej Marzec, Blanche Schwappach, 2021, GMDS.